• HyperFluor™ 594: Quantifying Plaque Biology

  2026-09-03

  Discover how a goat anti-rabbit IgG secondary antibody can translate causal atherosclerosis findings into spatially resolved protein measurements. This guide connects ISG20 validation, multiplex assay design, spectral control, and quantitative imaging without confusing detection with causality.

• Rotenone Workflows for Complex I and ROS Studies

  2026-09-02

  Rotenone provides a controllable way to impose mitochondrial Complex I stress in neuronal and cardiac-cell workflows, linking ATP loss and ROS to apoptosis, pyroptosis, ferroptosis, and autophagy responses. This practical guide connects dose selection, orthogonal assays, and troubleshooting to findings from a diabetic cardiomyopathy study.

• Amyloid Beta-Peptide (1-40): Beyond Plaques

  2026-09-02

  A mechanistic and translational framework for using human Aβ40 to connect amyloid state, microglial signaling, neurotoxicity, and experimental reproducibility. The article interprets emerging evidence that monomeric amyloid beta may regulate microglial inflammatory activity while outlining how researchers can use a sequence-defined peptide to separate physiological signaling from aggregation-driven pathology.

• Polygodial for TRPA1 Channel Activation

  2026-09-01

  Polygodial provides a chemically defined trigger for connecting TRPA1 ion channel modulation with calcium entry, NFAT signaling, and inflammatory readouts. This practical workflow shows how to build acute, causal, and epithelial assay layers while controlling solvent, timing, and cytotoxicity variables.

• Amyloid Beta-Peptide (1-40) (human) Workflow

  2026-08-31

  Build reproducible Aβ40 aggregation, imaging, and cell-exposure workflows with practical controls for peptide handling and fibril-state verification. Translate the reference study’s ratiometric fluorescence strategy into an amyloid fibril formation study, neurotoxicity mechanism investigation, or therapeutic screening assay.

• CARMIL Membrane Binding Controls Actin Assembly

  2026-08-31

  Mooren and colleagues show that the CARMIL membrane-binding domain does more than localize capping protein: it can recruit and activate capping protein at lipid surfaces, then disengage after capping protein binding. This membrane release provides a mechanistic explanation for how CARMIL may coordinate barbed-end uncapping with soluble capping protein activity during Arp2/3-dependent actin assembly.

• Protoporphyrin IX in Ferroptosis Workflows

  2026-08-30

  Build reproducible Protoporphyrin IX assays by separating light-driven photodynamic biology from iron-handling and ferroptosis measurements. This workflow connects heme formation, HCC mechanism studies, and photodynamic cancer diagnosis while emphasizing fresh formulation and rigorous controls.

• Phosbind Acrylamide: From Mobility Shift to Mechanism

  2026-08-29

  Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by translating phosphate-dependent binding into an SDS-PAGE mobility shift. This guide uses the 2026 FDXR–AKT study to show how gel-based evidence can distinguish phosphorylation state from its functional consequences.

• Ionomycin Free Acid in Calcium-to-FAK Research

  2026-08-29

  A translational framework for using Ionomycin free acid to interrogate calcium-dependent FAK stability, Calpain 2 activity, adhesion phenotypes, and the FAISL mechanism in triple-negative breast cancer assays.

• miR-18a, ALOXE3, and Ferroptosis in Glioblastoma

  2026-08-28

  The reference study identifies a miR-18a/ALOXE3 axis that links altered lipid metabolism to both ferroptosis resistance and enhanced migration in glioblastoma. Its integrated cellular, molecular, lipid-mediator, and orthotopic-model experiments suggest that ALOXE3 loss is a mechanistic driver of tumor progression rather than merely a disease-associated expression change.

• Ezh2–p53 Control of Neat1 in Inflammasomes

  2026-08-28

  The reference study identifies a methyltransferase-independent role for Ezh2 in maintaining H3K27 acetylation and chromatin accessibility at the lncRNA Neat1 promoter. It further shows that p53 competes with Ezh2 and recruits SIRT1 to repress Neat1, establishing an epigenetic control point for ASC oligomerization and inflammasome activation.

• Fluo-4 AM Calcium Assay Kit for Mechanotransduction

  2026-08-27

  Translate scaffold mechanics into live-cell calcium signals with a sensitive, no-wash workflow built for annulus fibrosus research. The assay also supports scalable intracellular calcium detection and GPCR inhibitor or agonist screening when rapid, plate-compatible readouts are needed.

• Berberine Hydrochloride for Metabolic Assays

  2026-08-27

  Berberine Hydrochloride offers a defined small-molecule workflow for connecting AMPK-driven metabolic phenotypes with LDL receptor, apoptosis, and ferroptosis readouts. This article shows how to control solubility, build concentration–time experiments, and cautiously extend the compound into sterile-inflammation assays inspired by acute kidney injury research.

• DPPH Antioxidant Screening: Workflow & Applications

  2026-08-26

  Use DPPH for rapid, colorimetric prioritization of antioxidant-rich extracts and drug candidates, then strengthen conclusions with orthogonal assays and chemical profiling. A practical workflow helps distinguish true radical scavenging from solvent effects, sample color, and unstable reagent behavior.

• Fluorescein Tyramide and the Sensitivity Frontier

  2026-08-26

  A translational perspective on how tyramide-based fluorescence can strengthen mechanistic studies of oxytocin signaling, superior colliculus circuitry, and adversity-related behavioral phenotypes without overstating what signal amplification can prove.

454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page